<?xml version="1.0" encoding="utf-8"?>
<!-- generator="wordpress/1.5.1.2" -->
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
>

<channel>
	<title>Jouhoublog</title>
	<link>http://jouhoublog.jouhoukoukai.com</link>
	<description>Drug approvals and pharmaceutical affairs in Japan</description>
	<pubDate>Thu, 01 Mar 2007 16:11:16 +0000</pubDate>
	<generator>http://wordpress.org/?v=1.5.1.2</generator>
	<language>en</language>

		<item>
		<title>(Tami)flu (mis)fortune</title>
		<link>http://jouhoublog.jouhoukoukai.com/?p=17</link>
		<comments>http://jouhoublog.jouhoukoukai.com/?p=17#respond</comments>
		<pubDate>Thu, 01 Mar 2007 15:52:42 +0000</pubDate>
		<dc:creator>Samo</dc:creator>
		
	<category>Medicinal products</category>
		<guid>http://jouhoublog.jouhoukoukai.com/?p=17</guid>
		<description><![CDATA[	
	In direct contrast to earlier posting, Tamiflu caught again the public attention - this time for far from envious reason. 
	Two recent incidents - juvenile suicides without any underlying social cause, were widely published in Japan, including extensive coverage in two consecutive nights on February 26 and 27, 2007 by the national TV broadcaster NHK. [...]]]></description>
		<wfw:commentRSS>http://jouhoublog.jouhoukoukai.com/?feed=rss2&amp;p=17</wfw:commentRSS>
	</item>
		<item>
		<title>Two blogs</title>
		<link>http://jouhoublog.jouhoukoukai.com/?p=16</link>
		<comments>http://jouhoublog.jouhoukoukai.com/?p=16#respond</comments>
		<pubDate>Fri, 09 Feb 2007 09:30:55 +0000</pubDate>
		<dc:creator>Samo</dc:creator>
		
	<category>General</category>
		<guid>http://jouhoublog.jouhoukoukai.com/?p=16</guid>
		<description><![CDATA[	Split and re-launched
	We are receiving on a daily basis numerous inquiries concerning the regulated medicinal products (drugs, quasi-drugs, medical devices and cosmetics) and the regulatory affairs in Japan. To further make world-wide available the researched answers we have provided to the professional users and customers, a new interactive repository - Recentanswers has been re-launched as [...]]]></description>
		<wfw:commentRSS>http://jouhoublog.jouhoukoukai.com/?feed=rss2&amp;p=16</wfw:commentRSS>
	</item>
		<item>
		<title>Speedy, isn&#8217;t it?</title>
		<link>http://jouhoublog.jouhoukoukai.com/?p=15</link>
		<comments>http://jouhoublog.jouhoukoukai.com/?p=15#respond</comments>
		<pubDate>Sat, 20 Jan 2007 07:33:50 +0000</pubDate>
		<dc:creator>Kanri</dc:creator>
		
	<category>Approvals</category>
	<category>Anticancers</category>
		<guid>http://jouhoublog.jouhoukoukai.com/?p=15</guid>
		<description><![CDATA[	
	In contrast to the chorused complains against the - as lobbyists put it - &#8220;glacier speed&#8221; of new drug approval in Japan, the chronology of Alimta shows quite the opposite. Let&#8217;s follow:
	
	In June 2005, it became clear that in addition to factory workers, many people living near the former factory operated by machinery maker Kubota [...]]]></description>
		<wfw:commentRSS>http://jouhoublog.jouhoukoukai.com/?feed=rss2&amp;p=15</wfw:commentRSS>
	</item>
		<item>
		<title>Another bridge</title>
		<link>http://jouhoublog.jouhoukoukai.com/?p=14</link>
		<comments>http://jouhoublog.jouhoukoukai.com/?p=14#respond</comments>
		<pubDate>Sun, 03 Dec 2006 08:11:53 +0000</pubDate>
		<dc:creator>Kanri</dc:creator>
		
	<category>General</category>
		<guid>http://jouhoublog.jouhoukoukai.com/?p=14</guid>
		<description><![CDATA[	One of the leading Japanese shosha (general trading company) announced that in 20:80 partnership with a large foreign biotech-oriented venture fund has set up a service company under the apt name JapanBridge. 
	In the past three decades, an untold number of &#34;Japan-bridging&#34; companies were planned, set up and even still existed by entrepreneurs from both [...]]]></description>
		<wfw:commentRSS>http://jouhoublog.jouhoukoukai.com/?feed=rss2&amp;p=14</wfw:commentRSS>
	</item>
		<item>
		<title>Silver lining of Iressa</title>
		<link>http://jouhoublog.jouhoukoukai.com/?p=13</link>
		<comments>http://jouhoublog.jouhoukoukai.com/?p=13#respond</comments>
		<pubDate>Sun, 12 Feb 2006 09:39:50 +0000</pubDate>
		<dc:creator>Kanri</dc:creator>
		
	<category>General</category>
	<category>Approvals</category>
	<category>Medicinal products</category>
	<category>Anticancers</category>
		<guid>http://jouhoublog.jouhoukoukai.com/?p=13</guid>
		<description><![CDATA[	If the approval of Iressa happened to be if not a cloud, but at least cloudy, it also has a silver lining. Both in response to the public criticism and along with the newer obligations concerning the pharmacovigilance, the authorities have decided to start disclosing information on advirse events (AEs) reported for medicines approved in Japan. [...]]]></description>
		<wfw:commentRSS>http://jouhoublog.jouhoukoukai.com/?feed=rss2&amp;p=13</wfw:commentRSS>
	</item>
		<item>
		<title>Warning before approval</title>
		<link>http://jouhoublog.jouhoukoukai.com/?p=12</link>
		<comments>http://jouhoublog.jouhoukoukai.com/?p=12#respond</comments>
		<pubDate>Fri, 02 Dec 2005 11:07:12 +0000</pubDate>
		<dc:creator>Kanri</dc:creator>
		
	<category>Approvals</category>
	<category>Medicinal products</category>
	<category>Anticancers</category>
		<guid>http://jouhoublog.jouhoukoukai.com/?p=12</guid>
		<description><![CDATA[	
Femara - an aromatase inhibitor - is known to be submitted and currently under a review by the Japanese regulatory authorities. Yet, as distributed today by the mass media, the warnings issued by Novartis AG were forwarded to the physicians in Japan as well. As read between the lines - under the provision of the Pharmaceutical [...]]]></description>
		<wfw:commentRSS>http://jouhoublog.jouhoukoukai.com/?feed=rss2&amp;p=12</wfw:commentRSS>
	</item>
		<item>
		<title>Flu fortune</title>
		<link>http://jouhoublog.jouhoukoukai.com/?p=11</link>
		<comments>http://jouhoublog.jouhoukoukai.com/?p=11#respond</comments>
		<pubDate>Thu, 24 Nov 2005 17:04:59 +0000</pubDate>
		<dc:creator>Kanri</dc:creator>
		
	<category>Medicinal products</category>
		<guid>http://jouhoublog.jouhoukoukai.com/?p=11</guid>
		<description><![CDATA[	In Japan the Pharmaceutical Affairs Law (PAL) permits individual import of both approved and unapproved drugs, as long as you have a prescription from Japanese physician. 
	Should we expect the Tamiflu to crash this winter the previous individual import record of Thalidomide (reportedly about 500,000 tablets were imported before the approval)?
	Tamiflu is sold in Japan [...]]]></description>
		<wfw:commentRSS>http://jouhoublog.jouhoukoukai.com/?feed=rss2&amp;p=11</wfw:commentRSS>
	</item>
		<item>
		<title>Anticancer PR</title>
		<link>http://jouhoublog.jouhoukoukai.com/?p=10</link>
		<comments>http://jouhoublog.jouhoukoukai.com/?p=10#respond</comments>
		<pubDate>Thu, 03 Nov 2005 07:41:07 +0000</pubDate>
		<dc:creator>Kanri</dc:creator>
		
	<category>Anticancers</category>
		<guid>http://jouhoublog.jouhoukoukai.com/?p=10</guid>
		<description><![CDATA[	In a rare PR move, the MHLW made publicly available through the mass media the previously adopted decision regarding changes in the approval qualification for anticancer drugs. Today Kyodo News Agency distributed in bilingual format the announcement that from April 1, 2006 the NDAs for anticancer drugs should include - along with the efficacy and [...]]]></description>
		<wfw:commentRSS>http://jouhoublog.jouhoukoukai.com/?feed=rss2&amp;p=10</wfw:commentRSS>
	</item>
		<item>
		<title>Quasi-drugs</title>
		<link>http://jouhoublog.jouhoukoukai.com/?p=9</link>
		<comments>http://jouhoublog.jouhoukoukai.com/?p=9#respond</comments>
		<pubDate>Tue, 13 Sep 2005 01:54:59 +0000</pubDate>
		<dc:creator>Kanri</dc:creator>
		
	<category>Medicinal products</category>
		<guid>http://jouhoublog.jouhoukoukai.com/?p=9</guid>
		<description><![CDATA[	We are receiving periodically inquiries regarding &#34;quasi-drugs&#34; in Japan, including about one recently mentioned. &#34;Quasi-drugs&#34; are the second category among all regulated medicinal products in Japan (along with drugs, medical devices and cosmetics).
	It is not clear how and when the term emerged, however the origin could be traced to the first translations in 1980s of [...]]]></description>
		<wfw:commentRSS>http://jouhoublog.jouhoukoukai.com/?feed=rss2&amp;p=9</wfw:commentRSS>
	</item>
		<item>
		<title>Anti-cancer pledge</title>
		<link>http://jouhoublog.jouhoukoukai.com/?p=8</link>
		<comments>http://jouhoublog.jouhoukoukai.com/?p=8#respond</comments>
		<pubDate>Sun, 28 Aug 2005 01:32:55 +0000</pubDate>
		<dc:creator>Kanri</dc:creator>
		
	<category>Anticancers</category>
		<guid>http://jouhoublog.jouhoukoukai.com/?p=8</guid>
		<description><![CDATA[	

In a course of the showdown prior the Lower House elections in Japan on September 11th, the major political parties published their &#34;manifests&#34;. The flavor of the foreign word has been used to increase the importance of those policy documents, what essentially are just party’s pledge.


	Such pledges - more or less vague, have been around [...]]]></description>
		<wfw:commentRSS>http://jouhoublog.jouhoukoukai.com/?feed=rss2&amp;p=8</wfw:commentRSS>
	</item>
	</channel>
</rss>
